ABVC BioPharma, Inc.

ABVC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $93.3K $18.6K $994.8K $0 $618 $13.4K $71.8K $2.8K
Accounts Receivable $0 $1.2K $0
Inventory $274 $795 $0
Total Current Assets $2.6M $173.5K $998.6K $795 $1.9K $48.3K $101.9K $33.2K
Property, Plant & Equipment $0 $0 $37.2K $46.8K $59.7K $41.9K
Goodwill
Intangible Assets (Excl. Goodwill) $64.6K $192.9K $207.2K $207.8K
Total Assets $2.6M $177.4K $1.0M $65.4K $232.0K $302.3K $369.4K $293.9K
Liabilities
Accounts Payable $27.9K $989.5K
Total Current Liabilities $4.4M $34.0K $2.1M $1.9M $1.8M $3.3M
Long-Term Debt
Total Liabilities $4.4M $6.6M $369.1K $34.0K $2.1M $1.9M $1.8M $3.3M
Stockholders' Equity
Retained Earnings $-15.8M $-11.3M $-315.6K $-23.2K $-30.6M $-30.3M $-28.8M $-25.8M
Total Stockholders' Equity $-1.8M $-6.5M $633.4K $31.4K $-1.9M $-1.6M $-1.5M $-3.0M
← Newer Page 2 of 2 Older →